Adobe Acrobat – bmj.q2733.full.pdf
View this file, and add comments too.
Related Articles
Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations – PubMed
Susceptibility to pancreatic adenocarcinoma appears to be linked to germ-line mutations in genes causing various familial cancer syndromes. The objectives of this study were to…
A lipid made by tumour cells reprograms immune cells
Nature – Insights into how cancer cells become unresponsive to therapy.
Can Community Pharmacies Help Address the NHS’s Growing Challenges?
Community pharmacies are seen as vital to easing NHS pressure. But challenges such as funding cuts and lack of integration persist.
Are Women Really Better Doctors Than Men?
A new study suggests you’re better off if your hospital physician is female.
Overtreatment of prostate cancer in the active surveillance era
Common sense thoughts on public health and conservative medicine from a family doctor in Lancaster, PA. kennylin I am a board-certified Family Physician and Public…
Kennedy’s lawyer has asked the FDA to revoke its approval of the polio vaccine | CNN
President-elect Donald Trump has praised the polio vaccine as the “greatest thing,” but a lawyer affiliated with Trump’s pick to lead the country’s top heath…
New Georgia law could make it easier for cancer patients to get access to personalized cancer care
Patty Watkins was diagnosed with stage 4 lung cancer in 2014. She says biomarker testing helped her doctors choose treatments most likely to work against…
Join Team Draft! Together we can Change The Face of Lung Cancer
Visit teamdraft.org and read 5 facts about lung cancer you may not know! Be sure to learn more about how you can join Team Draft…
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience
Blood Cancer Journal – Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience
